Submitted by James Love on 19. April 2013 - 5:20
In Geneva this week the US government is taking a harder line in the WIPO negotiations for a treaty on copyright exceptions for the blind, and the reason is simple -- lobbyists for the MPAA and publishers have been all over the White House, demanding a retreat from compromises made in February, and demanding that the Obama Administration push new global standards for technical protection measures, strip the treaty text of any reference to fair use and fair dealing, and impose new financial liabilities on libraries that serve blind people.
SCOTUS Oral Arguments in AMP v. Myriad Genetics; Court to Determine Answer to Question: Are Human Genes Patentable?Submitted by Krista Cox on 15. April 2013 - 12:05
On 15 April 2013, the Supreme Court of the United States heard oral arguments in the case Association for Molecular Pathology, et. al., v. Myriad Genetics, et. al, hearing arguments over the question: are human genes patentable? The case, which has been litigated since 2009, specifically involves two genes, known as the BRCA1 and BRCA2 genes which are associated with an individual's susceptibility to breast and ovarian cancer.
Submitted by thiru on 11. April 2013 - 3:17
On 11 April 2013, the United States made the following intervention on day 2 of the WIPO inter-sessional meeting on the protection of broadcasting organizations. The US noted the concerns expressed by content holders, technology companies, consumer and civil society groups about "creating extra layers of protection requiring additional clearance of rights".
Submitted by thiru on 10. April 2013 - 7:44
In 2007 the General Assembly of the World Intellectual Property Organization (WIPO) buried the broadcast treaty in cold storage when it decided (WO/GA/34/16) that the convening of a Diplomatic Conference for the Protection of Broadcasting Organizations could only take place "after agreement on objectives, specific scope and object of protection has been achieved." Commenting on the broadcast treaty and the break down in negotiations, KEI noted in 2007:
Submitted by James Love on 10. April 2013 - 4:16
This week the WIPO Standing Committee is holding a meeting to consider a possible treaty for broadcasting organizations. KEI thought this treaty negotiation had been blocked by fundamental differences over the purposes and scope of the treaty in 2007, but in the past few years the US Copyright office asked to put the issue back on the SCCR agenda, and subsequently Francis Gurry and Ambassador Trevor Clarke from the WIPO Secretariat have pushed to reach a conclusion, and more recently South Africa, Mexico, Japan and some other countries are now quite active, in favor of a new treaty.
Submitted by thiru on 5. April 2013 - 12:19
In the final phase of negotiations leading towards the Marrakesh Diplomatic Conference to conclude a Treaty for the Blind, Visually Impaired and other Reading Disabled Persons (17 June 2013 to 28 June 2013), it is important to take stock of where things stand in respect of the current negotiations.
Submitted by James Love on 3. April 2013 - 8:07
In a bid to generate sympathy for its defeat in the Supreme Court of India over efforts to evergreen patent protection for the cancer drug imatinib (trade names Gleevec or Glivec) in developing countries, Novartis has been making increasingly spectacular claims as regards its investments in the development of the drug.
Submitted by thiru on 3. April 2013 - 3:54
In the final stretch towards the Marrakesh Diplomatic Conference to conclude a Treaty for the Blind, Visually Impaired and other Reading Disabled Persons (17 June 2013 to 28 June 2013), it is perhaps important to take note of one important area of divergence, namely, the language contained in Article F of the Draft Text of an International Instrument/Treaty on Limitations and Exceptions for Visually Impaired Persons/Persons with Print Disabilities (SCCR/25/2 REV) w
Submitted by James Love on 1. April 2013 - 6:36
There is so much that one could say about today's decision, it is hard to know where to start.
Submitted by Krista Cox on 28. March 2013 - 11:14
On 28 March 2013, the EU-India FTA (BTiA) negotiating text was made available here. Below are some of my quick impressions on some portions of the negotiating text.
Submitted by KEI Staff on 28. March 2013 - 10:13
Earlier KEI published sections of the the EU India Negotiating FTA/BTIA negotiating text dealing with enforcement, along with some commentary on Article 17-31: http://keionline.org/node/1681.
On March 28, 2013, KEI obtained another document with Article 1-5,7-8,10-33 of the negotiating next. The new text is available at http://keionline.org/node/1691
Krista Cox will be providing her impressions here: http://keionline.org/node/1693
Here are KEI's quick reactions to the text.
Among the provisions in the TRIPS which protect consumers are Article 7, 8 and 40.
Submitted by James Love on 28. March 2013 - 9:37
This is a copy of the negotiating text for the India-EU Broad-based Trade and Investment Agreement (BTIA), also referred to as the India/EU FTA. It does not include Article 6, which I assume concerns patents, or have any text for Article 9 on Geographical Indications. The text includes country positions. We are not certain of the date of this text. KEI has some commentary at http://keionline.org/node/1692
Consolidated draft India-EU FTA (BTIA)
Art. 1 – Definition [Agreed]
Submitted by James Love on 27. March 2013 - 20:00
Knowledge Ecology International (KEI) comments
Name: James Love
Knowledge Ecology International (KEI) comments
U.S. House of Representatives, Committee on Ways and Means, Subcommittee on Trade, March 13, 2013 Hearing on U.S.-India Trade Relations
Name: James Love
Organization: Knowledge Ecology International
Address: 1621 Connecticut Avenue NW, Suite 500, Washington, DC 20009
Phone Number: 1.202.332.2670
Contact E-mail Address: James.Love@KEIonline.Org
Title of Hearing: U.S.-India Trade Relations
Submitted by James Love on 25. March 2013 - 13:47
On March 13, 2013, the U.S. House of Representative held a hearing on U.S.-India Trade Relations. Among the several topics under discussion were "the issuance of compulsory licenses, patent revocations, and other policies on pharmaceuticals" in India.
SCOTUS Oral Arguments in FTC v. Actavis; Court to Decide Legality of Pay-For-Delay (Reverse Payment) Settlement AgreementsSubmitted by Krista Cox on 25. March 2013 - 11:30
On Monday, 25 March 2013, the Supreme Court of the United States heard oral arguments in the case, Federal Trade Commission v. Actavis, Inc., et. al. This case had previously been captioned as Federal Trade Commission v. Watson Pharmaceuticals, et. al., but was recaptioned after the combination of Actavis and Watson. KEI filed an amicus brief in support of the FTC which is available here (along with additional background to the case).